Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for Elevance Health in a research ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurosense Therapeutics Ltd. (NRSN – Research Report), ...

A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma ...

The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...

Pre-earnings options volume in Oscar Health (OSCR) is 4.7x normal with calls leading puts 8:1. Implied volatility suggests the market is ...

WESPAC Advisors SoCal LLC raised its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 2.5% during the 4th quarter, ...

Childress Capital Advisors LLC boosted its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 13.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 691 ...

The portfolio’s return was -3.89% (net) for the reporting period vs. MSCI World Index that returned -0.16% for the same ...

The portfolio’s return was -5.34% (net) for the reporting period vs. MSCI World Index that returned -0.16% for the same ...